Cardinal Health, Inc.
CAH
Get informed when a big investor buys or sells
+ FollowEarnings Call Q3 2026
April 30, 2026 - AI Summary
Exclusive for Stockcircle Pro members
Sign up
Current Fair Value
2.3% downsideOvervalued by 2.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $52.43 Billion |
|---|---|
| Enterprise Value | $57.41 Billion |
| Dividend Yield | $2.04 (0.91%) |
| Earnings per Share | $6.48 |
| Beta | 0.53 |
| Outstanding Shares | 235,000,000 |
Return
| Return on Equity | -55.05% |
|---|---|
| Return on Assets | 2.75% |
| Return on Invested Capital | 14.88% |
Valuation & Multiples
| P/E Ratio | 33.74 |
|---|---|
| PEG | -159.57 |
| Price to Sales | 0.21 |
| Price to Book Ratio | -18.65 |
| Enterprise Value to Revenue | 0.23 |
| Enterprise Value to EBIT | 26.25 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | -3.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8922▲ 1.17% |
|---|---|
| Total Calls | 1,512,503▼ 6.59% |
| Total Puts | 1,349,495▼ 5.35% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 84.98%▼ 3.22% |
|---|---|
| Total Invested | $42.27B▼ 0.93% |
| Investors Holding | 1,467▲ 17.00% |
ESG Score
No data
About Cardinal Health, Inc.
Relevant Senate Committees
This committee controls taxation, trade, and entitlement spending, particularly Medicare and Medicaid. Reimbursement policies and funding levels for these programs directly impact the financial health of Cardinal Health's customers, profoundly affecting demand and pricing in the medical supplies market.
This committee allocates discretionary federal spending. Its subcommittees determine the precise funding for healthcare programs (e.g., NIH, VA, Medicare/Medicaid administrative costs), which directly impacts the revenue streams of Cardinal Health's customers (hospitals, clinics) and the overall healthcare market.
This committee directly regulates the FDA, which oversees many of the medical devices and pharmaceuticals that Cardinal Health distributes. It also influences labor laws, impacting Cardinal Health's workforce, and funding for health research, affecting future product availability.